The technology that begs from others will never be secure, and the chip industry and the medical industry are the best examples.

Bluestar Biotech and Pharmaceutical's gene therapy technology has already achieved initial results, and Lin Tianwei has also given Chen Nuo a research plan for the next five years. As long as Chen Nuo agrees, the creator of genes can be launched at any time.

Bluestar Group and Huaguo no longer need the cancer treatment technology of Western countries, and Bluestar Group has created more effective treatment technology.

Xiao Ping didn't expect that all the rich gifts she prepared for the Blue Star Group were rejected by Chen Nuo, and she couldn't get over her face.

As the president of Squibb in Greater China, Xiao Hui has another identity this time, a negotiator in the medical field of the United States. She already felt that she was lowering her status to negotiate with the Blue Star Group, but she didn't expect the Blue Star Group to be so ignorant.

Xiao Ping said with a frosty face: "I hope that Chairman Chen will think about it again, the Ommy market is not always open for you." ”

Chen Nuo also said: "I hope that the Miguo Pharmaceutical and Medical Group represented by your company can reduce the cost of tumor drug treatment as soon as possible and accumulate a little reputation for yourself, otherwise it will be too late to regret it." ”

The two went toe-to-toe and gave in, and the negotiations broke down.

Xiao Ping returned to the Lion City Greater China headquarters with great resentment, and then she will go to New York to personally report the content of the negotiations.

Sure enough, a week later, the medical department of the United States announced in an authoritative way that the gene treatment plan of Bluestar Biotechnology and Medical Company did not comply with the medical laws of the United States and was an illegal treatment method, and advised the Chinese people to go to China for treatment with caution.

There is a reason why the United States announced this: the gene therapy of Bluestar Biology and Medical Company did not go through a strict medical experiment process from theory to clinical promotion, he did not go through animal experiments, did not report to the relevant departments of the United States for approval, did not conduct a large number of clinical experiments, and did not have the necessary conditions for medical means and drug marketing.

For the sake of the health of citizens, 米国ZF still hopes that patients will not be greedy for the cheap of China and continue to use traditional treatments.

At the end of the announcement, the medical department of the United States said: "The traditional treatment of oncological diseases has been practiced for 20 years and has rich clinical data. On the other hand, the so-called gene therapy methods in some countries have only been in the process of being theoretically promoted for a few months, so I hope you can identify them. ”

The United States has always been a leader in global medicine, and the products of the United States and European pharmaceutical companies must be approved by the United States Medical and Drug Agency before they can be marketed and sold all over the world.

The verification certificate issued by the medical department of the United States has basically become the most valuable certificate in this industry.

Now the medical department of the United States has directly denied the gene therapy of the Blue Star Group, which is quite fatal to the Blue Star Group.

After the news was announced, it basically cut off the way of Bluestar Group's gene therapy to the United States and Europe.

The universal values of Westerners are also based on the bloody law of capital, and only after satisfying the interests of capitalists can there be so-called cures and salvations.

Bluestar Group's gene therapy is indeed flawed in its procedures, and it has not undergone a large number of animal experiments and clinical trials on Earth, but it does not mean that it has not undergone these tests in the Bluestar world.

The Blue Star World can even create gene people, and the gene therapy technology has been clinically applied for decades, which is much more reliable than the traditional therapy in the United States.

Dai Yanfei passed the announcement of the medical department of the United States to Chen Nuo, waiting for Chen Nuo to take an idea.

"It's very tricky, and doing this is tantamount to blocking the way for our technology to go abroad. Western medicine is based on the judgment of the United States, and the United States has come to the conclusion that it is difficult for the European Union to pass China's gene therapy technology. ”

"Really?" Chen Nuo smiled, "The people of Mi are sparing no effort." ”

Dai Yanfei said: "We have cut off the way of life of the western medicine company in China, and this is just the beginning, and there will be more drastic actions in the future." Is there anything we can do about it? ”

Chen Nuo threw the question to Liu Jiangfeng and said, "Mr. Liu, what do you say?" ”

Liu Jiangfeng has long been dissatisfied with what Mi Guo has done, and said: "I have a suggestion when I arrive. Didn't Westerners make a medical trip in order to make money for the profits of Chinese patients? Allowing Chinese patients to travel to the United States at a high price is actually doing medical treatment, and the price is not expensive, in addition to the normal support of medical expenses, there are also high service fees. We can invite foreign tenders to invite relevant tourism companies in China to participate in medical trips, and we can also let patients from Omi countries go on medical trips to China, in addition to our normal medical expenses, but also let the travel companies make some money. Mutual benefit and sharing can also expand the external influence of Bluestar Group's medical industry. When Westerners know that our gene therapy is effective, the official warning of the United States is also ineffective. ”

Chen Nuo was satisfied with Liu Jiangfeng's suggestion and said, "I'll leave this matter to you." Don't the people of the United States say that our technology does not have as many side effects as clinical trials? Let's carry out medical trips for omega patients, so that these patients can experience first-hand whether it is better to use gene technology in China, or to take hundreds of thousands of anti-cancer drugs in a course of medicine in China. Let the medical department of the United States see whether their warning announcement is useful. ”

Liu Jiangfeng's heart was agitated, and he traveled to Huaguo for medical treatment. This is something that I didn't dare to think of in the past, and this is not a question of making money, but a question that can absolutely prove the level of medical care in Huaguo.

"I'll do it right away!"

Chen Nuo said: "Fei Fei, what is the current situation of the major hospitals in China? ”

Dai Yanfei: "There are 15 hospitals in the country that have reached the level of tertiary and above and have cooperated with our genetic research institute, and we will provide them with treatment technology and personnel, so that the pressure on Jiangcheng People's Hospital will be relieved a lot." ”

Chen Nuo said: "The remaining medical resources of Jiangcheng People's Medicine can just accept some foreign medical tourists, increase the consumption of foreign medical tourists, and use the extra money to compensate the cost of gene therapy for ordinary people in China." ”

"I'll do it right away!" A week later, Bluestar Group invited a public tender to welcome China's outstanding tourism companies to open up medical travel routes to China, and Bluestar Group will select three to five excellent travel companies to cooperate with each other to provide reliable and guaranteed gene therapy plans for patients around the world.

The relevant departments of the United States felt that the gene therapy technology of the Bluestar Group was not credible, and the travel companies in Huaguo did not think so, and the crazy bidding began.

Keep in mind that the first domain name :.com this book. The mobile version of the mobile version of the wonderful book house is :.com